Related Experiment Videos
[Neonatal chronic lung disease]
1Universidade de São Paulo (USP), São Paulo, SP, Brazil.
Jornal De Pediatria
|December 20, 2003
Summary
Neonatal chronic lung disease (CLD) is increasingly common in preterm infants. Management requires individualized treatment and crucial outpatient follow-up, addressing nutritional and social needs for better outcomes.
Area of Science:
- Neonatology
- Pediatric Pulmonology
Background:
- Chronic lung disease (CLD) in neonates is a growing concern due to improved survival rates of preterm infants.
- Understanding the pathophysiology of neonatal CLD is critical, with prematurity and respiratory support being key factors.
Purpose of the Study:
- To review the pathophysiology and outpatient follow-up of neonatal chronic lung disease.
- To highlight the complexities in diagnosis and management of this condition.
Main Methods:
- A comprehensive Medline search was conducted for relevant articles on neonatal chronic lung disease since its initial description in 1967.
- Review of existing literature to synthesize information on pathophysiology, treatment, and follow-up.
Main Results:
- Neonatal CLD incidence is rising, driven by increased survival of premature infants.
- Pathophysiology involves prematurity and respiratory assistance; treatment is complex and individualized, with controversial drug indications.
- Essential outpatient follow-up must encompass nutritional and social aspects for optimal prognosis.
Conclusions:
- Neonatal CLD is often under-recognized by pediatricians, especially concerning post-discharge care.
- Severe cases necessitate specialized centers with advanced resources.
- Prognosis varies widely, influenced by prematurity complications and timely intervention.